Abstract:M‐yeast efficiently target and colonize in the tumor site, where they compete with tumor cells for glucose consumption, thereby disrupting glycolysis of cancer cells, resulting in the reduction of lactate accumulation, reversal of the acidosis of tumor microenvironment and reprogramming the tumor immunosuppressive microenvironment. Glucose is an important energy source for living cells. Particularly, most tumor cells use glycolysis to harness energy for their fast growth, invasion and metastasis even under aerobic conditions. Thus, reduction of the glucose level in cancer can lead to suppression of tumor growth. Here, macrophage membrane dressed yeast, Trojan M‐yeast, is developed, via coating the surface of yeast with macrophage membrane, for targeted accumulation and suppression of tumor by glucose starvation. Due to the inflammatory homing effects of macrophage membrane, M‐yeast efficiently target and colonize in the inflammatory tumor site, where they compete with tumor cells for glucose consumption, thereby disrupting glycolysis of cancer cells, resulting in the reduction of lactate accumulation and reversal of the acidosis of tumor microenvironment. Subsequently, the apoptotic tumor cells and yeast promote dendritic cell maturation, increase tumor‐infiltrating cytotoxic T lymphocytes. Meanwhile, ethanol and acetaldehyde produced by yeast metabolism of glucose can re‐polarize tumor associated macrophages (TAMs) to the anti‐tumor phenotype (M1), thus reprogramming the tumor immunosuppressive microenvironment, leading to synergistic tumor suppression together with glucose starvation, which is different from traditional chemotherapy and immunotherapy. M‐yeast exhibits promising targeted cancer therapy with a decent safety profile. This work may provide new insights as well as a new paradigm for yeast‐based cancer therapy.

Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy

Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors

Tumor Metabolism Destruction Via Metformin-Based Glycolysis Inhibition and Glucose Oxidase-Mediated Glucose Deprivation for Enhanced Cancer Therapy

Surface functionalized biomimetic bioreactors enable the targeted starvation-chemotherapy to glioma

A Nanoenzyme Reactor Fueled by a High-Glucose Microenvironment for Augmented Diabetic Tumor Therapy

A “Valve‐Closing” Starvation Strategy for Amplification of Tumor‐Specific Chemotherapy

In Situ Colonization of Trojan‐Yeast for Targeted Glucose Starvation and Reconstruction of Tumor Immune Environment

Tumor-activatable Biomineralized Nanotherapeutics for Integrative Glucose Starvation and Sensitized Metformin Therapy

Interference of Glucose Bioavailability of Tumor by Engineered Biohybrids for Potentiating Targeting and Uptake of Antitumor Nanodrugs

A Customized Biohybrid Presenting Cascade Responses to Tumor Microenvironment

Engineering probiotic biohydrogen micro-factories to initiate reductive stress for boosting tumor vulnerability

Nano-Clustered Cascaded Enzymes for Targeted Tumor Starvation and Deoxygenation-Activated Chemotherapy Without Systemic Toxicity.

Metabolic Regulation-Mediated Reversion of the Tumor Immunosuppressive Microenvironment for Potentiating Cooperative Metabolic Therapy and Immunotherapy

Genetically engineering glycolysis in T cells increases their antitumor function

Tumor-targeted biocatalyst with self-accelerated cascade reactions for enhanced synergistic starvation and photodynamic therapy

Central Role of Lactate and Proton in Cancer Cell Resistance to Glucose Deprivation and Its Clinical Translation

Engineering Clinically Relevant Probiotics with Switchable "nano‐promoter" and "nano‐effector" for Precision Tumor Therapy

Click-Nucleic-Acid-Containing Codelivery System Inducing Collapse of Cellular Homeostasis for Tumor Therapy Through Bidirectional Regulation of Autophagy and Glycolysis.

Cascade-reaction-triggered Engineering Nanocatalytic Theranostics Reconstructing Tumor Microenvironment Through Synergistic Oxidative Damage and Aerobic Glycolysis Inhibition Against Colon Cancer

Glycolytic Pathway As A Target For Tumor Inhibition

Tumor Starvation Induced Spatiotemporal Control over Chemotherapy for Synergistic Therapy.